D3 Pharma is a privately owned specialty pharmaceutical company based in the United Kingdom. It is committed to the research, development and commercialisation of licensed high-strength vitamin D medicinal products for the treatment of vitamin D deficiency, insufficiency and associated conditions. D3 Pharma’s pioneering work in the vitamin D deficiency area aims to address a significant unmet need and improve product access in the UK, Europe and worldwide. Our goal is to provide physicians, nutritionists and other healthcare professionals with high-quality, high-strength, clinically effective vitamin D3 products that can be used to provide rapid repletion and maintenance of vitamin D levels in both children and adults. Our high-strength product range will include vitamin D3 (cholecalciferol) at oral doses of 20,000 and 40,000 International Units (IU).